Concord Biotech Limited (CONCORDBIO.NS) share price
Concord Biotech Limited (NSE:CONCORDBIO.NS) last traded at INR 612.2, down 8.99% on the day (quote 2026-11-08 10:00 UTC), with a market cap of INR 12809.2 Cr and a 52-week range of INR 493.5 to INR 807.5.
| Exchange | NSE |
|---|---|
| Currency | INR |
| Last price | INR 612.2 |
| 1-day move | -8.99% |
| 52-week range | INR 493.5 - INR 807.5 |
| Market cap | INR 12809.2 Cr |
| From 52-week high | -24.20% |
| Volume vs average | 0.6x |
| Falling Shares risk score | 42/100 (ELEVATED) |
| Country | India |
| ISIN | INE338H01029 |
Frequently asked questions
Why is Concord Biotech Limited falling today?
Concord Biotech Limited (NSE:CONCORDBIO.NS) is down 8.99% at its latest quote and trades 24.2% below its 52-week high. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.
What is the Concord Biotech Limited share price today?
Concord Biotech Limited (NSE:CONCORDBIO.NS) last traded at INR 612.2, a -8.99% move on the day as of 2026-11-08 10:00 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the 52-week range of Concord Biotech Limited?
Concord Biotech Limited's 52-week low is INR 493.5 and its 52-week high is INR 807.5; the shares trade 24.2% below the high.
What is the market cap of Concord Biotech Limited?
Concord Biotech Limited has a market capitalisation of about INR 12809.2 Cr at the latest price.
What are the risks of investing in Concord Biotech Limited?
Falling Shares Intelligence rates Concord Biotech Limited 42/100 (ELEVATED) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com